By Dietrich Knauth NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of opi ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to [email protected]) ...

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims by state and municipal governments and individuals.

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors including US states and other parties more than $7.

Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying more than their previously ...

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of ...

Purdue Pharma has filed a revised bankruptcy plan to finalize a $7.4 billion opioid settlement after the U.S. Supreme Court blocked its previous deal. The plan seeks to resolve lawsuits accusing the ...

Purdue Pharma is seeking approval from a bankruptcy judge for its reorganization plan, which aims to dissolve the company and ...